References
Hanested BR. Diab Res Clin Pract 19: 139–149, 1993
Eiser C, Tooke JE. PharmacoEconomics 4: 85–91, 1993
DCCT Research Group. Diabetes Care 11: 725–732, 1988
Wikby A, et al. Quality of Life Res 2: 281–286, 1993
Hornquist JO, et al. Diab Res Clin Pract 10: 221–230, 1990
Lloyd CE, et al. Diabetes Care 15: 166–172, 1992
Gall MA, et al. Diabetes Res 11: 97–101, 1989
Sangeleer M, Czarka M. Acta Therapeutica 16: 139–149, 1990
Selam JL, et al. Diabetes Care 15: 877–885, 1992
DCCT Research Group. N Engl J Med 329: 977–986, 1993
DCCT Research Group. Diabetes 35: 530–545, 1986
DCCT Research Group. Diabetes Care 11: 567–573, 1988
DCCT Research Group. Am J Med 90: 450–459, 1991
Coyle D, Tolley K. PharmacoEconomics 2: 153–162, 1992
Lasker RD. N Engl J Med 329: 1035–1036, 1993
Rights and permissions
About this article
Cite this article
IDDM need not deprive patients of the good life. Drugs Ther. Perspect 3, 14–16 (1994). https://doi.org/10.2165/00042310-199403010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403010-00007